EUVIMEDEUVIMED entdecken
Crossref

Factors associated with lung function response with oral antibiotic treatment of pulmonary exacerbations in cystic fibrosis

Ana C Blanchard, Michelle Shaw, Felix Ratjen, Elizabeth Tullis, Nick Daneman, Valerie Waters

Journal of Cystic Fibrosis · 2023

DOI: 10.1016/j.jcf.2023.06.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2023. Verfasst von Ana C Blanchard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, 3175 Chemin de la Côte Sainte-Catherine, Montr…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Cystic Fibrosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 11 Literaturangaben. Gefördert von: Cystic Fibrosis Canada, Fonds de Recherche du Québec - Santé.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary exacerbations treated with oral antibiotics (oPEx) have a significant effect on lung function decline in people with cystic fibrosis (CF). However, factors associated with lung function response with oPExs are not well defined. We performed a retrospective cohort study of pediatric and adult patients with CF followed in the Toronto CF Database. Lung function response was measured both as the change in forced expiratory volume in 1 second (FEV1) from Day 0 of antibiotic therapy to end of treatment as well as from baseline to end of treatment. Drop from baseline to Day 0 FEV1 was strongly associated with lung function response (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsCystic FibrosisAdultHumansMaleFemaleChildRetrospective StudiesDisease ProgressionLungForced Expiratory Volume

Stichwörter der Autor:innen

Cystic fibrosisOral antibioticsPulmonary exacerbation

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, 3175 Chemin de la Côte Sainte-Catherine, Montreal, Quebec H3T 1C5, Canada.
  • Translational Medicine Research Program, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto M5G 1 × 8, Canada.
  • Translational Medicine Research Program, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto M5G 1 × 8, Canada; Division of Respiratory Medicine, Department of Pediatrics, The Hospital…
  • Division of Respiratory Medicine, Department of Medicine, St Michael's Hospital, University of Toronto, 30 Bond St, Toronto, M5B 1W8, Canada.
  • Division of Infectious Diseases, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto M4N 3M5, Canada.
  • Translational Medicine Research Program, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto M5G 1 × 8, Canada; Division of Infectious Diseases, Department of Pediatrics, The Hospital f…

Förderung

  • Cystic Fibrosis Canada
  • Fonds de Recherche du Québec - Santé

Zitieren

APA

Blanchard, A. C., Shaw, M., Ratjen, F., Tullis, E., Daneman, N., & Waters, V. (2023). Factors associated with lung function response with oral antibiotic treatment of pulmonary exacerbations in cystic fibrosis. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2023.06.015

Vancouver

Blanchard AC, Shaw M, Ratjen F, Tullis E, Daneman N, Waters V. Factors associated with lung function response with oral antibiotic treatment of pulmonary exacerbations in cystic fibrosis. Journal of Cystic Fibrosis. 2023. doi:10.1016/j.jcf.2023.06.015

BibTeX
@article{Blanchard2023,
  author = {Blanchard, Ana C and Shaw, Michelle and Ratjen, Felix and Tullis, Elizabeth and Daneman, Nick and Waters, Valerie},
  title = {Factors associated with lung function response with oral antibiotic treatment of pulmonary exacerbations in cystic fibrosis},
  journal = {Journal of Cystic Fibrosis},
  year = {2023},
  doi = {10.1016/j.jcf.2023.06.015}
}
Kostenlos starten →